ENDRA Life Sciences's market cap is currently $2.44M. The company's EPS TTM is $-1172.196; its P/E ratio is ―; ENDRA Life Sciences is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-4.10. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -275.45K	$ -234.26K	$ -224.41K	$ -165.25K	$ -115.01K
Operating Income	$ -10.52M	$ -13.16M	$ -11.50M	$ -11.50M	$ -10.84M
EBITDA	$ -9.78M	$ -12.94M	$ -11.01M	$ -11.33M	$ -10.84M
Net Income	$ -10.06M	$ -13.20M	$ -11.19M	$ -11.97M	$ -15.55M
Balance Sheet
Cash & Short-Term Investments	$ 2.83M	$ 4.89M	$ 9.46M	$ 7.23M	$ 6.17M
Total Assets	$ 6.75M	$ 9.27M	$ 12.87M	$ 8.76M	$ 7.18M
Total Debt	$ 394.40K	$ 546.63K	$ 678.96K	$ 685.47K	$ 707.07K
Net Debt	$ -2.44M	$ -4.34M	$ -8.78M	$ -6.54M	$ -5.47M
Total Liabilities	$ 1.10M	$ 2.07M	$ 2.09M	$ 1.60M	$ 2.42M
Stockholders' Equity	$ 5.66M	$ 7.20M	$ 10.78M	$ 7.17M	$ 4.76M
Cash Flow
Free Cash Flow	$ -9.58M	$ -12.97M	$ -11.17M	$ -10.82M	$ -8.63M
Operating Cash Flow	$ -9.55M	$ -12.77M	$ -11.12M	$ -10.77M	$ -8.59M
Investing Cash Flow	$ -24.72K	$ -202.58K	$ -45.00K	$ -51.33K	$ -43.59K
Financing Cash Flow	$ 7.52M	$ 8.40M	$ 13.40M	$ 11.88M	$ 8.34M

Currency in USD

ENDRA Life Sciences Earnings and Revenue History

Income Statement >

ENDRA Life Sciences Debt to Assets

Balance Sheet >

ENDRA Life Sciences Cash Flow

Cash Flow >

ENDRA Life Sciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing